Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1982 1
1988 1
1991 1
1995 1
1996 2
1998 1
1999 1
2002 2
2003 1
2004 1
2005 1
2006 1
2007 2
2008 2
2009 1
2010 4
2011 6
2012 27
2013 49
2014 73
2015 51
2016 39
2017 53
2018 96
2019 146
2020 263
2021 376
2022 567
2023 894
2024 548

Text availability

Article attribute

Article type

Publication date

Search Results

2,876 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Showing results for board editorial r
Your search for Board editoriale R retrieved no results
Onconephrology 2022: An Update.
Bonilla M, Gudsoorkar P, Wanchoo R, Herrmann SM, Jhaveri KD. Bonilla M, et al. Kidney360. 2023 Feb 1;4(2):258-271. doi: 10.34067/KID.0001582022. Epub 2022 Dec 9. Kidney360. 2023. PMID: 36821617 Free PMC article. Review.
Rethinking Chemistry.
Danielmeier K, Schreiner PR. Danielmeier K, et al. Angew Chem Int Ed Engl. 2023 Sep 4;62(36):e202311238. doi: 10.1002/anie.202311238. Angew Chem Int Ed Engl. 2023. PMID: 37646352
Rethinking Chemistry indicates the Board's desire to encourage scientists to approach chemistry in a new way, with a focus on reconsidering the field from many different angles. By taking a holistic approach, the Board intends to foster innovative, sustainable, and …
Rethinking Chemistry indicates the Board's desire to encourage scientists to approach chemistry in a new way, with a focus on reconsi …
The Epidemiology of Revision Total Knee Arthroplasty.
Tarazi JM, Chen Z, Scuderi GR, Mont MA. Tarazi JM, et al. J Knee Surg. 2021 Nov;34(13):1396-1401. doi: 10.1055/s-0041-1735282. Epub 2021 Sep 10. J Knee Surg. 2021. PMID: 34507367 Review.
ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.
Lovell-Badge R, Anthony E, Barker RA, Bubela T, Brivanlou AH, Carpenter M, Charo RA, Clark A, Clayton E, Cong Y, Daley GQ, Fu J, Fujita M, Greenfield A, Goldman SA, Hill L, Hyun I, Isasi R, Kahn J, Kato K, Kim JS, Kimmelman J, Knoblich JA, Mathews D, Montserrat N, Mosher J, Munsie M, Nakauchi H, Naldini L, Naughton G, Niakan K, Ogbogu U, Pedersen R, Rivron N, Rooke H, Rossant J, Round J, Saitou M, Sipp D, Steffann J, Sugarman J, Surani A, Takahashi J, Tang F, Turner L, Zettler PJ, Zhai X. Lovell-Badge R, et al. Stem Cell Reports. 2021 Jun 8;16(6):1398-1408. doi: 10.1016/j.stemcr.2021.05.012. Epub 2021 May 27. Stem Cell Reports. 2021. PMID: 34048692 Free PMC article. Review.
Nature prescribing.
Garside R, Lovell R, Husk K, Sowman G, Chapman E. Garside R, et al. BMJ. 2023 Dec 13;383:2745. doi: 10.1136/bmj.p2745. BMJ. 2023. PMID: 38164636 No abstract available.
Announcing the Editorial Board Fellowship Program of the American Journal of Physiology-Lung Cellular and Molecular Physiology.
Shimoda LA, Bai C, Bartlett NW, Bastarache JA, Feghali-Bostwick C, Kuebler WM, Prakash YS, Schmidt EP, Morty RE. Shimoda LA, et al. Am J Physiol Lung Cell Mol Physiol. 2021 Jul 1;321(1):L116-L118. doi: 10.1152/ajplung.00239.2021. Epub 2021 Jun 9. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34105373 Free PMC article. No abstract available.
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Wiendl H, et al. Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648. doi: 10.1177/17562864211039648. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34422112 Free PMC article. Review.
Analytical Science Advances announces its new Associate Editorial Board.
Trevorrow P, Petras D, Anderson LC, Luzzatto Knaan T, Saviola AJ, Rzagalinski I, Khan MS, Dudzik D, Dewaele D, Carloni LE, Tu Q, Hu Y, Hempel BF. Trevorrow P, et al. Anal Sci Adv. 2022 Jan 6;3(1-2):1-2. doi: 10.1002/ansa.202100901. eCollection 2022 Feb. Anal Sci Adv. 2022. PMID: 38716060 Free PMC article. No abstract available.
2,876 results